Abstract
In this issue of Blood, Perrot et al reveal that patients with multiple myeloma (MM) who are eligible for transplantation and have undetectable minimal residual disease (MRD) by next-generation sequencing (NGS) during maintenance therapy have excellent outcomes.1
Cite
CITATION STYLE
APA
San-Miguel, J. F., & Paiva, B. (2018, December 6). How deep is the myeloma iceberg? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-10-878637
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free